Animals with confirmed tumour growth in bone were treated with saline, doxorubicin (2 mg/kg, days 18 and 25), zoledronic acid (100 μg/kg day 19, equivalent to the 4-mg clinical dose), zoledronic acid and doxorubicin simultaneously, or doxorubicin followed 24 hours later by zoledronic acid.
C hemical modification of the proteins of bone matrix.— Glutaraldehyde cross-linking. Three segments of demineralized rat bone matrix were treated in 100 ml of each of the following aqueous solutions of glutaraldehyde at 2 C for one hour: 1, 2, 5, 10, 100, 1,000 and 2,000 mM/liter before implantation.
On the other side of the jaw, three implants were placed and the bone defects were treated in a similar fashion, but without membrane covering.
Between 1982 and 2009, 25 patients with bone cysts were treated in our hospital with distraction osteogenesis.
Eighty patients with intramedullary osteosarcoma in the long bones of the extremities were treated in Daping Hospital, Third Military Medical University in China from 1968 to 1993.
But she suspects France has faced greater terror because "the French [radical Muslims] had more of a bone to pick with how they were treated in society than the Germans".
Eighty patients with long bone intramedullary osteosarcoma in the extremities were treated in Daping Hospital (Chongqing, China) between 1968 and 1993.
The fact that approximately 80% of all pediatric long bone fractures are treated in the Children's hospitals in Bern and Lausanne could lead to potential publication biaz assuming that the remaining 20% of long bone fractures could present differently.
The blood and bone marrow samples that had been treated in culture with fludarabine (∼10 cells) were initially incubated for 15 min with anti-CD19 PerCP and anti-CD5 APC-conjugated monoclonal antibody (MoAb) (DAKO, Denmark) at room temperature.
The blood and bone marrow samples that had been treated in culture with resveratrol, fludarabine, cladribine, or a mixture of these drugs (∼10 cells) were initially incubated for 15 min with anti-CD19 PE-Cy5 and anti-CD5 APC-conjugated monoclonal antibodies (mAb) (DAKO, Glostrup, Denmark) at room temperature.
